Detalhe da pesquisa
1.
Phase 1 safety and immunogenicity evaluation of ADVAX, a multigenic, DNA-based clade C/B' HIV-1 candidate vaccine.
PLoS One
; 5(1): e8617, 2010 Jan 25.
Artigo
Inglês
| MEDLINE | ID: mdl-20111582
2.
Phase 1 safety and immunogenicity evaluation of ADMVA, a multigenic, modified vaccinia Ankara-HIV-1 B'/C candidate vaccine.
PLoS One
; 5(1): e8816, 2010 Jan 25.
Artigo
Inglês
| MEDLINE | ID: mdl-20111599